Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Oncogenes"" wg kryterium: Temat


Starter badań:

Tytuł :
[Effects of K-ras gene silence on the expression of oncogenes in HBE cells treated with PM(2.5)].
Autorzy :
Li RB; School of Public Health, University of South China, Hengyang 421001, China Institute of Environment and Health, Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China.
Pu JN; School of Public Health, University of South China, Hengyang 421001, China Institute of Environment and Health, Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China.
Li BR; Institute of Environment and Health, Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China Xiangya School of Public Health, Central South University, Changsha 410078, China.
Cai Y; School of Public Health, University of South China, Hengyang 421001, China Institute of Environment and Health, Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China.
Zhang ZH; School of Public Health, University of South China, Hengyang 421001, China.
Xu XY; Institute of Environment and Health, Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China.
Pokaż więcej
Źródło :
Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases [Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi] 2021 Nov 20; Vol. 39 (11), pp. 825-830.
Typ publikacji :
Journal Article
MeSH Terms :
Genes, ras*/genetics
Oncogenes*
Epithelial Cells ; Humans ; Particulate Matter/toxicity ; Proto-Oncogene Proteins c-fos/genetics
Czasopismo naukowe
Tytuł :
Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells.
Autorzy :
Brown G; Institute of Clinical Sciences, School of Biomedical Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Sep 07; Vol. 22 (18). Date of Electronic Publication: 2021 Sep 07.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Oncogenes*
Proto-Oncogenes*
Cell Lineage/*genetics
Neoplastic Stem Cells/*metabolism
Animals ; Biomarkers, Tumor ; Cell Transformation, Neoplastic/genetics ; Cell Transformation, Neoplastic/metabolism ; Epigenesis, Genetic ; Humans ; Neoplastic Stem Cells/pathology ; Oncogene Proteins, Fusion/genetics ; Oncogene Proteins, Fusion/metabolism ; Proto-Oncogene Mas
Czasopismo naukowe
Tytuł :
Review: Regeneration of the tail in lizards appears regulated by a balanced expression of oncogenes and tumor suppressors.
Autorzy :
Alibardi L; Comparative Histolab Padova and Dipartmento di Biologia, Universita' di Bologna, Italy. Electronic address: .
Pokaż więcej
Źródło :
Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft [Ann Anat] 2022 Jan; Vol. 239, pp. 151824. Date of Electronic Publication: 2021 Aug 31.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Genes, Tumor Suppressor*
Lizards*
Oncogenes*
Regeneration*
Tail/*growth & development
Animals ; Cell Differentiation ; Dermis ; Epidermis
Czasopismo naukowe
Tytuł :
The Novel Phosphatase Domain Mutations Q171R and Y65S Switch PTEN from Tumor Suppressor to Oncogene.
Autorzy :
Garrido JAMG; Disease Molecular Biology and Epigenetics Laboratory, National Institute of Molecular Biology and Biotechnology, University of the Philippines Diliman, Quezon City 1101, Philippines.
Alcantara KMM; Disease Molecular Biology and Epigenetics Laboratory, National Institute of Molecular Biology and Biotechnology, University of the Philippines Diliman, Quezon City 1101, Philippines.
Danac JMC; Disease Molecular Biology and Epigenetics Laboratory, National Institute of Molecular Biology and Biotechnology, University of the Philippines Diliman, Quezon City 1101, Philippines.
Serrano FEC; Disease Molecular Biology and Epigenetics Laboratory, National Institute of Molecular Biology and Biotechnology, University of the Philippines Diliman, Quezon City 1101, Philippines.
Cutiongco-de la Paz EM; Institute of Human Genetics, University of the Philippines Manila, Manila 1000, Philippines.; Philippine Genome Center, University of the Philippines System, Diliman, Quezon City 1101, Philippines.
Garcia RL; Disease Molecular Biology and Epigenetics Laboratory, National Institute of Molecular Biology and Biotechnology, University of the Philippines Diliman, Quezon City 1101, Philippines.; Philippine Genome Center, University of the Philippines System, Diliman, Quezon City 1101, Philippines.
Pokaż więcej
Źródło :
Cells [Cells] 2021 Dec 05; Vol. 10 (12). Date of Electronic Publication: 2021 Dec 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Genes, Tumor Suppressor*
Oncogenes*
Mutation/*genetics
PTEN Phosphohydrolase/*genetics
Actins/metabolism ; Animals ; Apoptosis ; Caspase 3/metabolism ; Caspase 7/metabolism ; Cell Movement/genetics ; Cell Proliferation ; Cell Shape ; Cytoskeleton/metabolism ; HCT116 Cells ; Humans ; Mice ; Mutant Proteins/metabolism ; NIH 3T3 Cells ; Phosphorylation ; Proto-Oncogene Proteins c-akt/metabolism
Czasopismo naukowe
Tytuł :
Higher order genetic interactions switch cancer genes from two-hit to one-hit drivers.
Autorzy :
Park S; Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain. .
Supek F; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. .; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. .
Lehner B; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. .; Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. .; Universitat Pompeu Fabra (UPF), Barcelona, Spain. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Dec 03; Vol. 12 (1), pp. 7051. Date of Electronic Publication: 2021 Dec 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Genes, Tumor Suppressor*
Models, Genetic*
Oncogenes*
Carcinogenesis/*genetics
Neoplasms/*genetics
Alleles ; DNA Copy Number Variations ; Datasets as Topic ; Haploinsufficiency ; Humans ; Mutation
Czasopismo naukowe
Tytuł :
A recurrent chromosomal inversion suffices for driving escape from oncogene-induced senescence via subTAD reorganization.
Autorzy :
Zampetidis CP; Molecular Carcinogenesis Group, Department of Histology and Embryology, Faculty of Medicine, National Kapodistrian University of Athens, 11527 Athens, Greece.
Galanos P; Genome Integrity Group, Danish Cancer Society Research Center, 2100 Copenhagen, Denmark. Electronic address: .
Angelopoulou A; Molecular Carcinogenesis Group, Department of Histology and Embryology, Faculty of Medicine, National Kapodistrian University of Athens, 11527 Athens, Greece.
Zhu Y; Translational Epigenetics Group, Institute of Pathology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Polyzou A; Molecular Carcinogenesis Group, Department of Histology and Embryology, Faculty of Medicine, National Kapodistrian University of Athens, 11527 Athens, Greece.
Karamitros T; Unit of Bioinformatics and Applied Genomics, Department of Microbiology, Hellenic Pasteur Institute, 11521 Athens, Greece.
Kotsinas A; Molecular Carcinogenesis Group, Department of Histology and Embryology, Faculty of Medicine, National Kapodistrian University of Athens, 11527 Athens, Greece.
Lagopati N; Molecular Carcinogenesis Group, Department of Histology and Embryology, Faculty of Medicine, National Kapodistrian University of Athens, 11527 Athens, Greece.
Mourkioti I; Molecular Carcinogenesis Group, Department of Histology and Embryology, Faculty of Medicine, National Kapodistrian University of Athens, 11527 Athens, Greece.
Mirzazadeh R; Science for Life Laboratory, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77 Solna, Stockholm, Sweden.
Polyzos A; Sanford I. Weill Department of Medicine, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA.
Garnerone S; Science for Life Laboratory, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77 Solna, Stockholm, Sweden.
Mizi A; Translational Epigenetics Group, Institute of Pathology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Gusmao EG; Translational Epigenetics Group, Institute of Pathology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Sofiadis K; Translational Epigenetics Group, Institute of Pathology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Gál Z; Nucleolar Stress and Disease Group, Danish Cancer Society Research Center, 2100 Copenhagen, Denmark.
Larsen DH; Nucleolar Stress and Disease Group, Danish Cancer Society Research Center, 2100 Copenhagen, Denmark.
Pefani DE; Laboratories of Biology, Medical School, University of Patras, 26504 Rio, Greece.
Demaria M; University of Groningen (RUG), European Research Institute for the Biology of Aging (ERIBA), University Medical Center Groningen (UMCG), 9713 AV Groningen, the Netherlands.
Tsirigos A; Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.
Crosetto N; Science for Life Laboratory, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77 Solna, Stockholm, Sweden.
Maya-Mendoza A; DNA Replication and Cancer Group, Danish Cancer Society Research Center, 2100 Copenhagen, Denmark.
Papaspyropoulos A; Molecular Carcinogenesis Group, Department of Histology and Embryology, Faculty of Medicine, National Kapodistrian University of Athens, 11527 Athens, Greece.
Evangelou K; Molecular Carcinogenesis Group, Department of Histology and Embryology, Faculty of Medicine, National Kapodistrian University of Athens, 11527 Athens, Greece.
Bartek J; Genome Integrity Group, Danish Cancer Society Research Center, 2100 Copenhagen, Denmark; Science for Life Laboratory, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77 Solna, Stockholm, Sweden. Electronic address: .
Papantonis A; Translational Epigenetics Group, Institute of Pathology, University Medical Center Göttingen, 37075 Göttingen, Germany; Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany. Electronic address: .
Gorgoulis VG; Molecular Carcinogenesis Group, Department of Histology and Embryology, Faculty of Medicine, National Kapodistrian University of Athens, 11527 Athens, Greece; Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, University of Manchester, M20 4GJ Manchester, UK; Center for New Biotechnologies and Precision Medicine, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece; Faculty of Health and Medical Sciences, University of Surrey, Surrey GU2 7YH, UK. Electronic address: .
Pokaż więcej
Źródło :
Molecular cell [Mol Cell] 2021 Dec 02; Vol. 81 (23), pp. 4907-4923.e8. Date of Electronic Publication: 2021 Nov 17.
Typ publikacji :
Journal Article
MeSH Terms :
Cellular Senescence*
Chromosome Inversion*
Epithelial-Mesenchymal Transition*
Oncogenes*
Recombination, Genetic*
Chromosomes/*ultrastructure
Neoplasms/*genetics
Animals ; Bronchi/metabolism ; CRISPR-Cas Systems ; Cell Cycle ; Cell Transformation, Neoplastic ; Circadian Rhythm ; Computational Biology ; Epithelial Cells/metabolism ; Flow Cytometry ; Genomics ; Humans ; Karyotyping ; Mice ; Mice, SCID ; Neoplasms/metabolism ; Phenotype ; Protein Binding ; Protein Domains ; Senescence-Associated Secretory Phenotype
Czasopismo naukowe
Tytuł :
Lysine Acetyltransferase 2B predicts favorable prognosis and functions as anti-oncogene in cervical carcinoma.
Autorzy :
Li L; Department of Pathology, People's Hospital of Dongying District, Dongying City, Shandong Province, China.
Zhang J; Department of Pathology, People's Hospital of Dongying District, Dongying City, Shandong Province, China.
Cao S; Department of Gynecology, People's Hospital of Dongying District, Dongying City, Shandong Province, China.
Pokaż więcej
Źródło :
Bioengineered [Bioengineered] 2021 Dec; Vol. 12 (1), pp. 2563-2575.
Typ publikacji :
Journal Article
MeSH Terms :
Oncogenes*
Uterine Cervical Neoplasms/*enzymology
Uterine Cervical Neoplasms/*genetics
p300-CBP Transcription Factors/*metabolism
Adult ; Cell Line, Tumor ; Cell Proliferation/genetics ; Disease Progression ; Epithelial-Mesenchymal Transition/genetics ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Kaplan-Meier Estimate ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Neoplasm Metastasis ; Prognosis ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Uterine Cervical Neoplasms/pathology ; p300-CBP Transcription Factors/genetics
Czasopismo naukowe
Tytuł :
Chromothripsis followed by circular recombination drives oncogene amplification in human cancer.
Autorzy :
Rosswog C; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Else Kröner Forschungskolleg Clonal Evolution in Cancer, University Hospital Cologne, Cologne, Germany.
Bartenhagen C; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Welte A; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Kahlert Y; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Hemstedt N; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Lorenz W; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Cartolano M; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Ackermann S; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Perner S; Institute of Pathology, University of Luebeck and University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.; Pathology Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
Vogel W; Institute of Pathology, University of Luebeck and University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.; Pathology Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
Altmüller J; Cologne Center for Genomics (CCG), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Core Facility Genomics, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Nürnberg P; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Cologne Center for Genomics (CCG), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Hertwig F; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Göhring G; Department of Human Genetics, Hannover Medical School (MHH), Hannover, Germany.
Lilienweiss E; Department of Internal Medicine, University of Cologne, Cologne, Germany.
Stütz AM; European Molecular Biology Laboratory Genome Biology Unit, Heidelberg, Germany.
Korbel JO; European Molecular Biology Laboratory Genome Biology Unit, Heidelberg, Germany.
Thomas RK; Department of Translational Genomics, Medical Faculty, University of Cologne, Cologne, Germany.; Department of Pathology, University of Cologne, Cologne, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Peifer M; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany. .; Department of Translational Genomics, Medical Faculty, University of Cologne, Cologne, Germany. .
Fischer M; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany. .; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany. .
Pokaż więcej
Źródło :
Nature genetics [Nat Genet] 2021 Dec; Vol. 53 (12), pp. 1673-1685. Date of Electronic Publication: 2021 Nov 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Chromothripsis*
Gene Amplification*
Gene Rearrangement*
Oncogenes*
Neoplasms/*genetics
Cell Line, Tumor ; Cohort Studies ; DNA, Circular ; DNA, Neoplasm ; Humans ; Models, Genetic ; Mutation ; Neuroblastoma/genetics ; Whole Genome Sequencing
Czasopismo naukowe
Tytuł :
Decoding complex patterns of oncogene amplification.
Autorzy :
Pellman D; Howard Hughes Medical Institute, Chevy Chase, MD, USA. .; Blavatnick Institute, Department of Cell Biology, Harvard Medical School, Boston, MA, USA. .; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. .
Zhang CZ; Blavatnick Institute, Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
Pokaż więcej
Źródło :
Nature genetics [Nat Genet] 2021 Dec; Vol. 53 (12), pp. 1626-1627.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Gene Amplification*
Oncogenes*/genetics
Czasopismo naukowe
Tytuł :
Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1.
Autorzy :
Lo A; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Holmes K; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Kamlapurkar S; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Mundt F; Proteomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Oncology-Pathology, Karolinska Institute, 171 77 Stockholm, Sweden.
Moorthi S; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Fung I; Proteomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Fereshetian S; Proteomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Watson J; Proteomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Carr SA; Proteomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Mertins P; Proteomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Berger AH; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Pokaż więcej
Źródło :
Science signaling [Sci Signal] 2021 Nov 30; Vol. 14 (711), pp. eabc4520. Date of Electronic Publication: 2021 Nov 30.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Oncogenes*
ras Proteins*/genetics
Signal Transduction
Czasopismo naukowe
Tytuł :
A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors.
Autorzy :
Jia Y; Department of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Tian Q; Department of Reproductive Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.
Yang K; Department of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Liu Y; Department of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Liu Y; Department of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Pokaż więcej
Źródło :
BioMed research international [Biomed Res Int] 2021 Nov 20; Vol. 2021, pp. 5862941. Date of Electronic Publication: 2021 Nov 20 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Oncogenes*
Biomarkers, Tumor/*genetics
Biomarkers, Tumor/*immunology
CDC2-CDC28 Kinases/*genetics
CDC2-CDC28 Kinases/*immunology
Neoplasms/*genetics
Neoplasms/*immunology
CDC2-CDC28 Kinases/chemistry ; Cancer-Associated Fibroblasts/immunology ; Cancer-Associated Fibroblasts/pathology ; DNA Methylation ; Disease Progression ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/pathology ; Male ; Microsatellite Instability ; Mutation ; Neoplasms/pathology ; Prognosis ; Protein Conformation
Czasopismo naukowe
Tytuł :
Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma.
Autorzy :
Wu H; The NHC Key Laboratory of Drug Addiction Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.; International Research Center for Regenerative Medicine, BOAO International Hospital, Qionghai, Hainan, 571434, China.
Tian W; Yunnan Province Clinical Center for Bone and joint Diseases, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
Tai X; Yunnan Province Clinical Center for Bone and joint Diseases, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
Li X; Yunnan Province Clinical Center for Bone and joint Diseases, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
Li Z; The NHC Key Laboratory of Drug Addiction Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
Shui J; Shanghai International Travel Healthcare Center, Shanghai, 200000, People's Republic of China.
Yu J; The NHC Key Laboratory of Drug Addiction Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China. .
Wang Z; Yunnan Province Clinical Center for Bone and joint Diseases, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China. .
Zhu X; Yunnan Province Clinical Center for Bone and joint Diseases, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China. .
Pokaż więcej
Źródło :
BMC genomics [BMC Genomics] 2021 Nov 18; Vol. 22 (1), pp. 833. Date of Electronic Publication: 2021 Nov 18.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Pancreatic Ductal*/genetics
Oncogenes*
Pancreatic Neoplasms*/genetics
Biomarkers, Tumor ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; Humans ; Neoplasm Proteins ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Oncogene-dependent sloppiness in mRNA translation.
Autorzy :
Champagne J; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands.
Pataskar A; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands.
Blommaert N; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands.
Nagel R; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands.
Wernaart D; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands.
Ramalho S; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands.
Kenski J; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands.
Bleijerveld OB; Proteomics Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands.
Zaal EA; Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, the Netherlands.
Berkers CR; Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, the Netherlands.
Altelaar M; Proteomics Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, the Netherlands.
Peeper DS; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands.
Faller WJ; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands.
Agami R; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands; Erasmus MC, Rotterdam University, Rotterdam, the Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Molecular cell [Mol Cell] 2021 Nov 18; Vol. 81 (22), pp. 4709-4721.e9. Date of Electronic Publication: 2021 Sep 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Oncogenes*
Protein Biosynthesis*
Neoplasms/*genetics
RNA, Messenger/*metabolism
T-Lymphocytes/*cytology
Animals ; Carcinogenesis ; Cell Membrane/metabolism ; Disease Progression ; Drug Resistance, Neoplasm ; Frameshift Mutation ; Frameshifting, Ribosomal ; Humans ; Immunotherapy/methods ; MAP Kinase Signaling System ; Melanoma/metabolism ; Mice ; Neoplasms/metabolism ; Peptides/chemistry ; Protein Kinase Inhibitors ; Ribosomes/metabolism ; T-Lymphocytes/metabolism ; Tryptophan/chemistry ; Tryptophan/metabolism
Czasopismo naukowe
Tytuł :
Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration.
Autorzy :
Lawal B; PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan.; Graduate Institute of Cancer Biology & Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
Kuo YC; Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.; School of Post-baccalaureate Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung 40402, Taiwan.
Tang SL; Department of Pharmacy Practice, Tri-Service General Hospital, School of Pharmacy, National Defense Medical Center, Taipei 11490, Taiwan.
Liu FC; Department of Rheumatology/Immunology and Allergy, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan.
Wu ATH; The PhD Program of Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.; Clinical Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan.; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan.; Traditional Herbal Medicine Research Center of Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan.
Lin HY; PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan.; Graduate Institute of Cancer Biology & Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan.; Traditional Herbal Medicine Research Center of Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan.
Huang HS; PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan.; Graduate Institute of Cancer Biology & Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.; Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 11490, Taiwan.; PhD Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
Pokaż więcej
Źródło :
Cells [Cells] 2021 Oct 25; Vol. 10 (11). Date of Electronic Publication: 2021 Oct 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Oncogenes*
Benzamides/*pharmacology
Cholangiocarcinoma/*genetics
Cholangiocarcinoma/*immunology
Transcriptome/*genetics
AT-Hook Motifs ; Benzamides/chemistry ; Benzamides/therapeutic use ; Biomarkers, Tumor/metabolism ; Cell Line, Tumor ; Cholangiocarcinoma/drug therapy ; Cholangiocarcinoma/pathology ; DNA Methylation/drug effects ; DNA Methylation/genetics ; Disease Progression ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic/drug effects ; Gene Regulatory Networks ; HMGA2 Protein/chemistry ; Humans ; Immunophenotyping ; Ligands ; Molecular Docking Simulation ; Neoplasm Metastasis ; Neoplasm Proteins/genetics ; Neoplasm Proteins/metabolism ; Prognosis ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Risk Factors ; Small Molecule Libraries/chemistry ; Small Molecule Libraries/pharmacology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry.
Autorzy :
van Maldegem F; Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK. .; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081HZ, Amsterdam, The Netherlands. .
Valand K; Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Cole M; Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Patel H; Bioinformatics and Biostatistics Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Rana S; Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.; Lung Cancer Group, Division of Molecular Pathology, Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK.
Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Enfield K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Bah N; Bioinformatics and Biostatistics Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Kelly G; Bioinformatics and Biostatistics Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Tsang VSK; Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Mugarza E; Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Moore C; Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Hobson P; Flow Cytometry Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Levi D; Flow Cytometry Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Molina-Arcas M; Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6DD, UK.
Downward J; Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK. .; Lung Cancer Group, Division of Molecular Pathology, Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Oct 08; Vol. 12 (1), pp. 5906. Date of Electronic Publication: 2021 Oct 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Oncogenes*/drug effects
Image Cytometry/*methods
Tumor Microenvironment/*immunology
Animals ; Antibodies ; Antineoplastic Agents/pharmacology ; Carcinoma, Non-Small-Cell Lung/diagnostic imaging ; Carcinoma, Non-Small-Cell Lung/immunology ; Disease Models, Animal ; Lung Neoplasms/diagnostic imaging ; Lung Neoplasms/drug therapy ; Macrophages ; Mice ; Mice, Inbred C57BL ; T-Lymphocytes ; Tumor Microenvironment/drug effects
Czasopismo naukowe
Tytuł :
USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma.
Autorzy :
Prieto-Garcia C; Protein Stability and Cancer Group, Department of Biochemistry and Molecular Biology, University of Würzburg, 97074 Würzburg, Germany.; Comprehensive Cancer Centre Mainfranken, 97074 Würzburg, Germany.; Molecular Signaling Group, Institute of Biochemistry II, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany.
Tomašković I; Molecular Signaling Group, Institute of Biochemistry II, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany.
Shah VJ; Molecular Signaling Group, Institute of Biochemistry II, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany.
Dikic I; Molecular Signaling Group, Institute of Biochemistry II, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany.; Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany.
Diefenbacher M; Protein Stability and Cancer Group, Department of Biochemistry and Molecular Biology, University of Würzburg, 97074 Würzburg, Germany.; Comprehensive Cancer Centre Mainfranken, 97074 Würzburg, Germany.; Mildred Scheel Early Career Center, 97074 Würzburg, Germany.
Pokaż więcej
Źródło :
Cells [Cells] 2021 Oct 04; Vol. 10 (10). Date of Electronic Publication: 2021 Oct 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Genes, Tumor Suppressor*
Oncogenes*
Carcinoma, Squamous Cell/*genetics
Ubiquitin Thiolesterase/*genetics
Animals ; Carcinoma, Squamous Cell/therapy ; Humans ; Models, Molecular ; Ubiquitin Thiolesterase/antagonists & inhibitors ; Ubiquitin Thiolesterase/chemistry ; Ubiquitin Thiolesterase/metabolism
Czasopismo naukowe
Tytuł :
Autophagy Is Polarized toward Cell Front during Migration and Spatially Perturbed by Oncogenic Ras.
Autorzy :
Singh MK; Institut Curie, Centre de Recherche, Paris Sciences et Lettres Research University, 75005 Paris, France.; Institut National de la Santé et de la Recherche Médicale (INSERM), U830, 75005 Paris, France.
Zago G; Institut Curie, Centre de Recherche, Paris Sciences et Lettres Research University, 75005 Paris, France.; Institut National de la Santé et de la Recherche Médicale (INSERM), U830, 75005 Paris, France.
Veith I; Institut Curie, Centre de Recherche, Paris Sciences et Lettres Research University, 75005 Paris, France.; Institut National de la Santé et de la Recherche Médicale (INSERM), U830, 75005 Paris, France.
Camonis J; Institut Curie, Centre de Recherche, Paris Sciences et Lettres Research University, 75005 Paris, France.; Institut National de la Santé et de la Recherche Médicale (INSERM), U830, 75005 Paris, France.
Coppey M; Institut Curie, Centre de Recherche, Paris Sciences et Lettres Research University, 75005 Paris, France.; Centre National de la Recherche Scientifique (CNRS), UMR168, Sorbonne University, 75005 Paris, France.
Parrini MC; Institut Curie, Centre de Recherche, Paris Sciences et Lettres Research University, 75005 Paris, France.; Institut National de la Santé et de la Recherche Médicale (INSERM), U830, 75005 Paris, France.
Pokaż więcej
Źródło :
Cells [Cells] 2021 Oct 02; Vol. 10 (10). Date of Electronic Publication: 2021 Oct 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Autophagy*/genetics
Cell Movement*/genetics
Genes, ras*
Oncogenes*
Animals ; Cattle ; Cell Line ; Cell Nucleus/drug effects ; Cell Nucleus/metabolism ; Cell Transformation, Neoplastic/drug effects ; Cell Transformation, Neoplastic/pathology ; Collagen/pharmacology ; Gels/pharmacology ; Humans ; Image Processing, Computer-Assisted ; Lysosomes/drug effects ; Lysosomes/metabolism ; Microtubule-Associated Proteins/metabolism
Czasopismo naukowe
Tytuł :
Extra chromosomal DNA in different cancers: Individual genome with important biological functions.
Autorzy :
Karami Fath M; Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
Akbari Oryani M; Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Ramezani A; Department of Microbiology and Virology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Barjoie Mojarad F; Department of Radiology, Faculty of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Khalesi B; Department of Research and Production of Poultry Viral Vaccine, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization, Karaj, Iran.
Delazar S; Department of Radiology, Tehran University of Medical Sciences, Tehran, Iran.
Anjomrooz M; Department of Radiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Taghizadeh A; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Taghizadeh S; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Payandeh Z; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: .
Pourzardosht N; Biochemistry Department, Guilan University of Medical Sciences, Rasht, Iran. Electronic address: .
Pokaż więcej
Źródło :
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2021 Oct; Vol. 166, pp. 103477. Date of Electronic Publication: 2021 Sep 14.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Neoplasms*/genetics
Oncogenes*
DNA, Circular/*genetics
DNA, Neoplasm/*genetics
Carcinogenesis ; Humans
Czasopismo naukowe
Tytuł :
Detecting the formation of human c-KIT oncogene promoter G-Quadruplex by Taylor dispersion analysis.
Autorzy :
Yang Y; National and Local Joint Engineering Research Center of Biomedical Functional Materials, Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, Changzhou Institute of Innovation and Development, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210023, PR China.
Yang Y; National and Local Joint Engineering Research Center of Biomedical Functional Materials, Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, Changzhou Institute of Innovation and Development, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210023, PR China.
Wang S; National and Local Joint Engineering Research Center of Biomedical Functional Materials, Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, Changzhou Institute of Innovation and Development, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210023, PR China.
Li H; National and Local Joint Engineering Research Center of Biomedical Functional Materials, Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, Changzhou Institute of Innovation and Development, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210023, PR China. Electronic address: .
Chen DDY; Department of Chemistry, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada. Electronic address: .
Pokaż więcej
Źródło :
Talanta [Talanta] 2021 Oct 01; Vol. 233, pp. 122533. Date of Electronic Publication: 2021 May 19.
Typ publikacji :
Journal Article
MeSH Terms :
G-Quadruplexes*
Oncogenes*
DNA/genetics ; Humans ; Ligands ; Promoter Regions, Genetic
Czasopismo naukowe
Tytuł :
Impact of Oncogenic Targets by Tumor-Suppressive miR-139-5p and miR-139-3p Regulation in Head and Neck Squamous Cell Carcinoma.
Autorzy :
Koma A; Department of Oral Science, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Asai S; Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.; Department of Otorhinolaryngology/Head and Neck Surgery, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Minemura C; Department of Oral Science, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Oshima S; Department of Oral Science, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Kinoshita T; Department of Otorhinolaryngology/Head and Neck Surgery, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Kikkawa N; Department of Otorhinolaryngology/Head and Neck Surgery, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Koshizuka K; Department of Otorhinolaryngology/Head and Neck Surgery, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Moriya S; Department of Biochemistry and Genetics, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Kasamatsu A; Department of Oral Science, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Hanazawa T; Department of Otorhinolaryngology/Head and Neck Surgery, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Uzawa K; Department of Oral Science, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Seki N; Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Sep 14; Vol. 22 (18). Date of Electronic Publication: 2021 Sep 14.
Typ publikacji :
Journal Article
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Oncogenes*
Head and Neck Neoplasms/*genetics
MicroRNAs/*genetics
Squamous Cell Carcinoma of Head and Neck/*genetics
Base Sequence ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Gene Expression Profiling ; Head and Neck Neoplasms/pathology ; Humans ; MicroRNAs/metabolism ; Neoplasm Invasiveness ; Neoplasm Proteins/genetics ; Neoplasm Proteins/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Signal Transduction/genetics ; Squamous Cell Carcinoma of Head and Neck/pathology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies